Ratiometric fluorescence sensing of d-allulose using an inclusion complex of γ-cyclodextrin with a benzoxaborole-based probe

Because d-allulose has been attracting attention as a zero-calorie sugar, the selective sensing of d-allulose is desired to investigate its health benefits. We report herein a novel fluorescence chemosensor that is based on an inclusion complex of γ-cyclodextrin (γ-CyD) with a benzoxaborole-based probe. Two inclusion complexes, 1/γCyD and 2/γCyD, were prepared by mixing γ-CyD with their corresponding probes in a water-rich solvent, where γ-CyD encapsulates two molecules of the probes inside its cavity to form a pyrene dimer. Both 1/γCyD and 2/γCyD exhibit monomeric and dimeric fluorescence from the pyrene moieties. By the reaction of 1/γCyD with saccharides, the intensities of monomeric and dimeric fluorescence remained unchanged and decreased, respectively. We have demonstrated that 1/γCyD has much higher affinity for d-allulose than for the other saccharides (d-fructose, d-glucose, and d-galactose). The conditional equilibrium constants for the reaction systems were determined to be 498 ± 35 M^-1 for d-fructose, 48.4 ± 25.3 M^-1 for d-glucose, 15.0 ± 3.3 M^-1 for d-galactose, and (8.05 ± 0.59) × 10³ M^-1 for d-allulose. These features of 1/γCyD enable ratiometric fluorescence sensing with high sensitivity and selectivity for d-allulose. The limits of detection and quantification of 1/γCyD for d-allulose at pH 8.0 were determined to be 6.9 and 21 μM, respectively. Induced circular dichroism spectral study has shown that the reaction of 1/γCyD with d-allulose causes the monomerisation of the dimer of probe 1 that is encapsulated by γ-CyD, which leads to the diminishment of the dimeric fluorescence.

Precision synthesis for well-defined linear and/or architecturally controlled thermoresponsive poly(N-substituted acrylamide)s

We describe the progress in precision polymerizations of specific kinds of N-alkylacrylamides and N,N-dialkylacrylamides to produce polymers showing thermoresponsive properties in aqueous media, which representatively include the reversible-deactivation radical polymerizations...

Preparation of cross-linked poly(vinyl alcohol) films from copolymers with benzoxaborole and carboxylic acid groups, and their degradability in an oxidizing environment

Functionalized PVA films were prepared from copolymers with benzoxaborole and carboxyl groups.

Boron-incorporating hemagglutinating virus of Japan envelope (HVJ-E) nanomaterial in boron neutron capture therapy

Combining immunotherapeutic and radiotherapeutic technique has recently attracted much attention for advancing cancer treatment. If boron-incorporated hemagglutinating virus of Japan-envelope (HVJ-E) having high membrane fusion ability can be used as a boron delivery agent in boron neutron capture therapy (BNCT), a radical synergistic improvement of boron accumulation efficiency into tumor cells and antitumor immunity may be induced. In this study, we aimed to develop novel boron-containing biocompatible polymers modified onto HVJ-E surfaces. The copolymer consisting of 2-methacryloyloxyethyl phosphorylcholine (MPC) and methacrylamide benzoxaborole (MAAmBO), poly[MPC-co-MAAmBO], was successfully synthesized by using a simple free radical polymerization. The molecular structures and molecular weight of the poly[MPC-co-MAAmBO] copolymer were characterized by nuclear magnetic resonance and matrix-assisted laser desorption ionization time-of-flight mass spectrometry, respectively. The poly[MPC-co-MAAmBO] was coated onto the HVJ-E surface via the chemical bonding between the MAAmBO moiety and the sugar moiety of HVJ-E. DLS, AFM, UV-Vis, and fluorescence measurements clarified that the size of the poly[MPC-co-MAAmBO]-coated HVJ-E, HVJ-E/p[MPC-MAAmBO], to be about 130 ~ 150 nm in diameter, and that the polymer having 9.82 × 106 ~ 7 boron atoms was steadily coated on a single HVJ-E particle. Moreover, cellular uptake of poly[MPC-co-MAAmBO] could be demonstrated without cytotoxicity, and the hemolysis could be successfully suppressed by 20%. These results indicate that the HVJ-E/p[MPC-MAAmBO] may be used as boron nanocarriers in a combination of immunotherapy with BNCT.